CCL2 and myeloid sarcoma: One such molecule is the chemokine monocyte-chemotactic protein-1 (MCP-1, also known as CCL2), which is reported to contribute to the pathogenesis of MS [23,24], through its involvement in the migration of leukocytes into the CNS [25-27].